Skip to main content

Foyston, Gordon & Payne Inc

Position in ABBV — AbbVie Inc.

CIK 1322853 TORONTO, A6

Position in ABBV

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$3,070,008
+$416,630 QoQ
Shares Held
12,200
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#1,636
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Foyston, Gordon & Payne Inc holds $12,647,439 across 3 Drug Manufacturers - General names. ABBV ranks #2 (24.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ABBV
AbbVie Inc.
This page
12,200 $3,070,008

All Filings in ABBV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,070,008 12,200
2026-03-31 $2,653,378 12,200
2025-12-31 $2,787,578 12,200
2025-09-30 $2,824,788 12,200
2025-06-30 $2,264,564 12,200
2025-03-31 $2,556,144 12,200
2024-12-31 $2,167,940 12,200
2024-09-30 $2,409,256 12,200
2024-06-30 $2,092,544 12,200
2024-03-31 $2,229,268 12,242
2023-12-31 $1,897,142 12,242
2023-09-30 $1,824,792 12,242
2023-06-30 $1,649,364 12,242
2023-03-31 $1,951,007 12,242
2022-12-31 $1,978,429 12,242
2022-09-30 $1,642,998 12,242
2022-06-30 $1,874,984 12,242
2022-03-31 $1,984,550 12,242
2021-12-31 $1,651,880 12,200
2021-09-30 $1,316,014 12,200
2021-06-30 $1,374,208 12,200
2021-03-31 $1,320,284 12,200
2020-12-31 $1,307,230 12,200
2020-09-30 $1,068,598 12,200
2020-06-30 $1,197,796 12,200
2020-03-31 $929,518 12,200